| |
First in Human Study of AL-335; Single Dose,
Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1
|
| |
| |
https://clinicaltrials.gov/ct2/show/NCT02339207?term=AL-335&rank=1
This study is currently recruiting participants.
Verified January 2015 by Alios Biopharma Inc.
This randomized, double-blind, placebo-controlled, 3-part study will assess the safety, tolerability, and pharmacokinetics of orally administered AL-335 in healthy volunteers (HV) and subjects with CHC infection.
|
|
| |
| |
|
|
|
